Target intelligence / Profile preview

Tropomodulin-4 (TMOD4)

Target
TMOD4
Molecular classification
Other (specifically: actin-regulating/capping protein), Actin-binding protein
01

Overview

Tropomodulin-4 (TMOD4) is a member of the tropomodulin protein family and the predominant isoform in mammalian skeletal muscle. It acts as an actin-capping protein, binding to the pointed (minus) end of actin filaments, where it blocks both elongation and depolymerization. This function is essential for regulating thin filament length, maintaining sarcomere structure, and enabling effective muscle contraction. TMOD4’s activity is tropomyosin-dependent; it helps ensure the integrity of myofibrils during muscle development. Disruption of TMOD4 impairs sarcomere assembly and muscle organization, and it may be genetically associated with certain myopathies and forms of amyotrophic lateral sclerosis. TMOD4 is not known to be a direct target of any current drugs, nor is it used as a clinical biomarker or therapeutic agent.

Other names
Skeletal muscle tropomodulinactin-capping proteinskeletal tropomodulinSK-TMODSk-Tmodtropomodulin 4 (muscle)
02

Mechanism of action

no drugs known to act via TMOD4, so no therapeutic mechanism; its biological role is actin filament capping and stabilization

03

Biological functions

Actin filament organizationMuscle contractionMyofibril assembly (especially in skeletal muscle)Regulation of myogenesis and adipogenesis
04

Disease associations

Amyotrophic lateral sclerosis type 5 (genetic association)Dehydrated Hereditary Stomatocytosis 1 with or without Pseudohyperkalemia and/or Perinatal Edema (genetic association)Sarcomere assembly disorders/myopathies (animal studies; functional disruption)Other (potential association with muscle disease due to structural role)
05

Safety considerations

Disruption of TMOD4 leads to defective sarcomere assembly, severely impaired muscle contraction, and embryonic movement (animal knockout studies)No known therapeutic challenges, as it is not currently a drug target

Beyond the preview

Go deeper on Tropomodulin-4 (TMOD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tropomodulin-4 (TMOD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call